Hima Bindu A and Soumya D
HIV and diabetes are both chronic diseases that significantly affect the human lifestyle and their quality of living. When these two diseases coexist, their treatment would be overwhelming for patients. Highly active antiretroviral therapy (HAART) became the standard of care in HIV infection. As the treatment for HIV has been developed and the access to therapy has been improved, the incidence of HIV-associated diabetes began to grow. Diabetes can be an important consequence of HAART. This review describes various metabolic complications such as AIDS-related insulin resistance, Glucose Intolerance and Hyperglycemia after HAART and also gives a brief account on the control measures.
